精神分裂症首次发作后环境暴露与复发风险的甲基化谱评分

IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY
Alex-González Segura , Llucia Prohens , Laura Julià , Silvia Amoretti , Maria RIbero , Laura Pino-Camacho , Guillermo Cano-Escalera , Anna Mane , Roberto Rodriguez-Jimenez , Alexandra Roldan , Salvador Sarró , Angela Ibañez , Judith Usall , Antonio Lobo , Clemente Garcia-Rizo , Manuel Jesus Cuesta , Mara Parellada , Ana González-Pinto , Esther Berrocoso , Miquel Bernardo , Concepción De-la-Cámara
{"title":"精神分裂症首次发作后环境暴露与复发风险的甲基化谱评分","authors":"Alex-González Segura ,&nbsp;Llucia Prohens ,&nbsp;Laura Julià ,&nbsp;Silvia Amoretti ,&nbsp;Maria RIbero ,&nbsp;Laura Pino-Camacho ,&nbsp;Guillermo Cano-Escalera ,&nbsp;Anna Mane ,&nbsp;Roberto Rodriguez-Jimenez ,&nbsp;Alexandra Roldan ,&nbsp;Salvador Sarró ,&nbsp;Angela Ibañez ,&nbsp;Judith Usall ,&nbsp;Antonio Lobo ,&nbsp;Clemente Garcia-Rizo ,&nbsp;Manuel Jesus Cuesta ,&nbsp;Mara Parellada ,&nbsp;Ana González-Pinto ,&nbsp;Esther Berrocoso ,&nbsp;Miquel Bernardo ,&nbsp;Concepción De-la-Cámara","doi":"10.1016/j.euroneuro.2025.02.003","DOIUrl":null,"url":null,"abstract":"<div><div>Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed through the calculation of methylation profile scores (MPS). The aim of the present study is to evaluate the association of MPS as a surrogate marker of the biological impact of early stressful life events (including stressful intrauterine conditions and obstetric complications, childhood adversity and toxic habits), with the risk of schizophrenia (SCZ) relapse. 91 participants from a cohort of first-episode schizophrenia (FES) patients with less than five years of evolution were classified as non-relapse (patients who had not experienced a relapse after 3 years of enrollment) or relapse (patients who relapsed during the 3-year follow-up). As inclusion criteria, patients fulfilled Andreasen's criteria of symptomatic remission. Genome-wide DNA methylation (DNAm) was profiled and fourteen MPS reflecting environmental exposure were constructed including both early stressful life events (including stressful intrauterine conditions and delivery issues, childhood adversity) and toxic habits. Increased levels of MPS reflecting gestational diabetes (<em>p</em> = 0.009), hypertensive disorders during pregnancy (<em>p</em> = 0.004), pre-eclampsia (<em>p</em> = 0.049), early preterm birth (<em>p</em> = 0.030), childhood adversity abuse (<em>p</em> = 0.021) and all childhood adversity (<em>p</em> = 0.030) were significantly associated with an increased risk of relapse. Our study suggests that changes in specific methylation patterns may represent one of the biological mechanisms linking early stressful life events to an increased risk of relapse.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"94 ","pages":"Pages 4-15"},"PeriodicalIF":6.1000,"publicationDate":"2025-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia\",\"authors\":\"Alex-González Segura ,&nbsp;Llucia Prohens ,&nbsp;Laura Julià ,&nbsp;Silvia Amoretti ,&nbsp;Maria RIbero ,&nbsp;Laura Pino-Camacho ,&nbsp;Guillermo Cano-Escalera ,&nbsp;Anna Mane ,&nbsp;Roberto Rodriguez-Jimenez ,&nbsp;Alexandra Roldan ,&nbsp;Salvador Sarró ,&nbsp;Angela Ibañez ,&nbsp;Judith Usall ,&nbsp;Antonio Lobo ,&nbsp;Clemente Garcia-Rizo ,&nbsp;Manuel Jesus Cuesta ,&nbsp;Mara Parellada ,&nbsp;Ana González-Pinto ,&nbsp;Esther Berrocoso ,&nbsp;Miquel Bernardo ,&nbsp;Concepción De-la-Cámara\",\"doi\":\"10.1016/j.euroneuro.2025.02.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed through the calculation of methylation profile scores (MPS). The aim of the present study is to evaluate the association of MPS as a surrogate marker of the biological impact of early stressful life events (including stressful intrauterine conditions and obstetric complications, childhood adversity and toxic habits), with the risk of schizophrenia (SCZ) relapse. 91 participants from a cohort of first-episode schizophrenia (FES) patients with less than five years of evolution were classified as non-relapse (patients who had not experienced a relapse after 3 years of enrollment) or relapse (patients who relapsed during the 3-year follow-up). As inclusion criteria, patients fulfilled Andreasen's criteria of symptomatic remission. Genome-wide DNA methylation (DNAm) was profiled and fourteen MPS reflecting environmental exposure were constructed including both early stressful life events (including stressful intrauterine conditions and delivery issues, childhood adversity) and toxic habits. Increased levels of MPS reflecting gestational diabetes (<em>p</em> = 0.009), hypertensive disorders during pregnancy (<em>p</em> = 0.004), pre-eclampsia (<em>p</em> = 0.049), early preterm birth (<em>p</em> = 0.030), childhood adversity abuse (<em>p</em> = 0.021) and all childhood adversity (<em>p</em> = 0.030) were significantly associated with an increased risk of relapse. Our study suggests that changes in specific methylation patterns may represent one of the biological mechanisms linking early stressful life events to an increased risk of relapse.</div></div>\",\"PeriodicalId\":12049,\"journal\":{\"name\":\"European Neuropsychopharmacology\",\"volume\":\"94 \",\"pages\":\"Pages 4-15\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2025-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Neuropsychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0924977X25000264\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neuropsychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0924977X25000264","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

遗传和环境因素已被发现在精神病复发中发挥重要作用,无论是独立的还是通过它们的协同相互作用。近年来,通过甲基化谱分数(MPS)的计算提出了DNA甲基化(DNAm)。本研究的目的是评估MPS作为早期压力性生活事件(包括压力性宫内状况和产科并发症、童年逆境和有毒习惯)生物学影响的替代标志物与精神分裂症(SCZ)复发风险的关联。从病程少于5年的首发精神分裂症(FES)患者队列中选出91名参与者,将其分为非复发(入组3年后未复发的患者)或复发(3年随访期间复发的患者)。作为纳入标准,患者满足Andreasen的症状缓解标准。研究人员分析了全基因组DNA甲基化(DNAm),并构建了14个反映环境暴露的MPS,包括早期压力生活事件(包括压力宫内条件和分娩问题,童年逆境)和有毒习惯。MPS水平升高反映妊娠期糖尿病(p = 0.009)、妊娠期高血压疾病(p = 0.004)、先兆子痫(p = 0.049)、早产(p = 0.030)、童年逆境虐待(p = 0.021)和所有童年逆境(p = 0.030)与复发风险增加显著相关。我们的研究表明,特定甲基化模式的变化可能代表了将早期压力生活事件与复发风险增加联系起来的生物学机制之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia
Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed through the calculation of methylation profile scores (MPS). The aim of the present study is to evaluate the association of MPS as a surrogate marker of the biological impact of early stressful life events (including stressful intrauterine conditions and obstetric complications, childhood adversity and toxic habits), with the risk of schizophrenia (SCZ) relapse. 91 participants from a cohort of first-episode schizophrenia (FES) patients with less than five years of evolution were classified as non-relapse (patients who had not experienced a relapse after 3 years of enrollment) or relapse (patients who relapsed during the 3-year follow-up). As inclusion criteria, patients fulfilled Andreasen's criteria of symptomatic remission. Genome-wide DNA methylation (DNAm) was profiled and fourteen MPS reflecting environmental exposure were constructed including both early stressful life events (including stressful intrauterine conditions and delivery issues, childhood adversity) and toxic habits. Increased levels of MPS reflecting gestational diabetes (p = 0.009), hypertensive disorders during pregnancy (p = 0.004), pre-eclampsia (p = 0.049), early preterm birth (p = 0.030), childhood adversity abuse (p = 0.021) and all childhood adversity (p = 0.030) were significantly associated with an increased risk of relapse. Our study suggests that changes in specific methylation patterns may represent one of the biological mechanisms linking early stressful life events to an increased risk of relapse.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Neuropsychopharmacology
European Neuropsychopharmacology 医学-精神病学
CiteScore
10.30
自引率
5.40%
发文量
730
审稿时长
41 days
期刊介绍: European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信